Communicable Diseases, Emerging: Clinical Trials

2 trials for Communicable Diseases, Emerging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Terminated 1
Phase 32Recruiting 1, Terminated 1

Follow Communicable Diseases, Emerging: new trials by email Literature Review of Communicable Diseases, Emerging trials Research Report on Communicable Diseases, Emerging

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Favipiravir, Ribavirin, Dexamethasone - Lassa Fever
Phase 2 / Phase 3RecruitingIrrua Specialist Teaching Hospital17552025-05-022026-02-04
EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial
Baricitinib, Placebo - COVID-19, Emerging Infectious Disease
Phase 2 / Phase 3TerminatedOslo University Hospital2902021-06-032023-02-06

Narrower conditions

COVID-19 (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Lassa Fever (1)

Broader conditions

Communicable Diseases (2)  ·  Disease Attributes (2)  ·  Infections (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Arenaviridae Infections (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Respiratory Tract Diseases (1)

Interventions

Dexamethasone (1)  ·  Ribavirin (1)  ·  Standard of Care (1)  ·  baricitinib (1)  ·  favipiravir (1)

Sponsors

Irrua Specialist Teaching Hospital (1)  ·  Oslo University Hospital (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Italy (1)  ·  Liberia (1)  ·  Luxembourg (1)  ·  Nigeria (1)  ·  Norway (1)  ·  Portugal (1)  ·  Slovakia (1)

Top investigators

Domique Costagliola, PhD (1)  ·  Jose R Arribas, MD PhD (1)

Results publications

PMID 34473343, PMID 36627655